Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Other financing activities (2022 - 2025)

GE HealthCare Technologies' Other financing activities history spans 4 years, with the latest figure at -$25.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities fell 316.67% year-over-year to -$25.0 million, compared with a TTM value of -$81.0 million through Dec 2025, down 138.24%, and an annual FY2025 reading of -$81.0 million, down 138.24% over the prior year.
  • Other financing activities for Q4 2025 was -$25.0 million at GE HealthCare Technologies, up from -$41.0 million in the prior quarter.
  • The five-year high for Other financing activities was $7.0 million in Q1 2024, with the low at -$41.0 million in Q3 2025.
  • Average Other financing activities over 4 years is -$16.0 million, with a median of -$17.5 million recorded in 2022.
  • Year-over-year, Other financing activities soared 116.67% in 2023 and then crashed 1200.0% in 2024.
  • Tracing GEHC's Other financing activities over 4 years: stood at -$3.0 million in 2022, then crashed by 733.33% to -$25.0 million in 2023, then surged by 76.0% to -$6.0 million in 2024, then crashed by 316.67% to -$25.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Other financing activities are -$25.0 million (Q4 2025), -$41.0 million (Q3 2025), and -$9.0 million (Q2 2025).